Company Questions Remain Unanswered In FDA's Combo Products GMP Rule

FDA's proposed "streamlined approach" to combination product manufacturing raises a number of practical questions such as what elements are actual components of a combo product and at what stage the streamlined system kicks in, firms say

More from Archive

More from Medtech Insight